Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest HIV blood screening Stories

Over-the-Counter HIV Test Approved By FDA
2012-07-04 05:46:02

Connie K. Ho for redOrbit.com — Your Universe Online According to the U.S. Food and Drug Administration (FDA), there are approximately 40,000 newly-diagnosed HIV infections annually. Interestingly enough, a large number of the infections were passed by those who are unaware that they had been affected. With these staggering statistics, many researchers have worked to remedy the situation and one step was made in that direction when the FDA recently approved the OraQuick In-Home HIV...

Expert Health Panel Urges FDA To Approve In-Home HIV Test
2012-05-16 10:11:12

The US Food and Drug Administration (FDA) will be tasked with deciding the fate of a new over-the-counter HIV testing kit that would allow people to test for the virus in the privacy of their own home. The call was made by a panel of experts for the Blood Products Advisory Committee, who urged the federal regulatory agency to approve the new OraQuick In-Home HIV Test, saying it was safe and effective and that the benefits outweighed any risks. OraSure, the manufacturer of the device,...

2011-08-11 06:42:03

(Ivanhoe Newswire) -- What segment of the population currently has the highest rate of increase of HIV/AIDS cases?  The answer may come as a surprise; senior citizens! Take New Jersey for instance: in the last two years, state residents with HIV/AIDS aged 65 and over grew to over 15 percent! According to Marilyn Riley, a spokeswoman from the New Jersey Department of Health and Human Services, much of the rise can be linked to seniors not believing they are at risk.  Those in...

2010-11-03 08:00:00

ABBOTT PARK, Ill., Nov. 3, 2010 /PRNewswire/ -- Abbott today announced it has received a 2010 Chicago Innovation Award for its ARCHITECT HIV Ag/Ab Combo assay, the first test approved in the United States that can simultaneously detect both HIV antigens and antibodies. The HIV Ag/Ab Combo test was approved by the U.S. Food and Drug Administration and launched in September 2010, allowing patients to be diagnosed earlier than ever before. Studies conducted by the Centers for Disease Control...

2010-09-29 12:39:37

Detection of acute HIV infection (the stage of disease immediately after HIV acquisition but before HIV antibodies are detectable) with pooled nucleic acid amplification testing (that detects the presence of HIV genetic material in the blood before antibodies are detectable) is feasible but not cost-effective in all settings. Rather, pooled nucleic acid amplification testing after testing for antibodies with third-generation enzyme immunoassays (which can detect the first antibody to appear...

2010-06-21 09:54:00

Test advances ability to detect HIV infection earlier SILVER SPRING, Md., June 21 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved the first assay to detect both antigen and antibodies to Human Immunodeficiency Virus (HIV). This assay is approved for use as an aid in the diagnosis of HIV-1/HIV-2 infection in adults including pregnant women. It is also the first assay for use as an aid in the diagnosis of HIV-1/HIV-2 infection in children as young as two years...

2010-06-21 07:00:00

ABBOTT PARK, Ill., June 21 /PRNewswire-FirstCall/ -- Every nine and a half minutes, someone in the United States is infected with HIV, and one out of every five of these individuals doesn't know it. To help stem the spread of this disease, the U.S. Food and Drug Administration (FDA) today approved an innovative new diagnostic tool, which will allow patients to be diagnosed earlier than ever before. Abbott's ARCHITECT HIV Ag/Ab Combo assay is the first test approved in the United States...

2010-01-25 08:59:00

ABBOTT PARK, Ill., Jan. 25 /PRNewswire-FirstCall/ -- An assay to aid in the early detection of HIV infection may soon be available in the United States. Abbott (NYSE: ABT) announced today it has submitted a Premarket Approval application for the ARCHITECT HIV Ag/Ab Combo assay to the U.S. Food and Drug Administration (FDA) for expedited review. Upon approval, the assay is expected to be the first test available in the United States to simultaneously detect the combined presence of HIV...

2009-09-21 08:58:41

The U. S. Food and Drug Administration says it has approved the second screening test that detects HIV antibodies in donated blood and in organ transplants. The federal agency said the new test -- the Abbott Prism HIV O Plus assay -- is one of five assays that run on the fully automated Abbott Prism System. There are two types of HIV: HIV type 1 consists of various subgroups, including group M, the most common subgroup of the virus in the United States, and group O, found primarily in...

2009-09-18 14:59:00

SILVER SPRING, Md., Sept. 18 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced approval of the Abbott Prism HIV O Plus assay, as a screening tool designed to detect the presence of certain antibodies to HIV. The assay is one of five assays that run on the fully automated Abbott Prism System. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) There are two types of HIV. HIV type 1 consists of various subgroups, including group M, the most common...